市場調查報告書
商品編碼
990425

穩定性同位素標識化合物的全球市場:2020年∼2027年

Global Stable Isotope Labeled Compound Market - 2020-2027

出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球穩定性同位素標識化合物,由生物科技,製藥、農業、生物醫學部門的研究活動增加,和蛋白質體學研究增加促進。在全球各種癌症的盛行率上升,近幾年,是加速穩定性同位素標識化合物市場的重要要素之一。

本報告提供全球穩定性同位素標識化合物市場相關調查分析,產業分析,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

目錄

第1章 全球穩定性同位素標識化合物市場調查手法與調查範圍

第2章 全球穩定性同位素標識化合物市場:市場定義與市場概要

第3章 全球穩定性同位素標識化合物市場:摘要整理

第4章 全球穩定性同位素標識化合物市場:市場動態

  • 影響市場的要素
    • 促進因素
    • 阻礙因素
    • 機會
    • 影響分析

第5章 全球穩定性同位素標識化合物市場:產業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價格分析
  • 法規分析

第6章 全球穩定性同位素標識化合物市場:COVID-19分析

  • 對市場的COVID-19分析
  • COVID-19的價格趨勢
  • 供需頻譜
  • 大流行時的市場相關的政府舉措
  • 製造商策略性舉措
  • 結論

第7章 全球穩定性同位素標識化合物市場:各類型

  • 簡介
  • 重氫
  • 碳12,碳13
  • 氧16,氧18
  • 氮15
  • 鋰6,鋰7
  • 氯35,氯37
  • 硫磺34
  • 其他

第8章 全球穩定性同位素標識化合物市場:各用途

  • 簡介
  • 研究
  • 工業
  • 臨床診斷
  • 其他

第9章 全球穩定性同位素標識化合物市場:各終端用戶

  • 簡介
  • 製藥、生物科技企業
  • 醫院、診斷中心
  • 學術、研究機關
  • 其他

第10章 全球穩定性同位素標識化合物市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 南美
  • 亞太地區
  • 中東、非洲

第11章 全球穩定性同位素標識化合物市場:競爭情形

  • 競爭模式
  • 市場定位/佔有率分析
  • M&A分析

第12章 全球穩定性同位素標識化合物市場:企業簡介

  • Perkinelmer
  • Cambridge Isotope Laboratories, Inc
  • Merck KGaA
  • URENCO Limited
  • Trace Sciences International
  • IsoSciences LLC
  • Omicron Biochemicals, Inc
  • Huayi Isotopes Co
  • Alsachim
  • Taiyo Nippon Sanso Corporation等

第13章 全球穩定性同位素標識化合物:重要考察

第14章 全球穩定性同位素標識化合物:DataM

目錄

Market Overview

The global stable isotope-labeled compound market size was worth US$ XX billion in 2019 and is estimated to show significant growth by reaching up to US$ XX billion by 2027, growing at a CAGR of XX% during the forecast period (2020-2027).

Stable isotope-labeled compounds are non-reactive chemical substances where one or more than one element within a compound is substituted for its stable isotopes. The stable isotope-labeled products serve as a useful tool in the study of dynamic metabolomics and steady-state. These compounds show ideal properties for studying metabolic flux, as they precisely mimic endogenous natural abundance metabolites. Their significant role in assessing in vivo metabolism in a vast range of metabolic research has built a massive market for the research sector.

Stable isotopes are often paired with mass spectrometry or nuclear magnetic resonance to give dynamic information regarding turnover rate and physiological regulation. The coupling of the technologies mentioned above with stables isotopes has enabled researchers to better utilize stable isotope-labeled compounds for evaluating drug disposition and their toxicity profiling before using it on the patient population.

Apart from gaining popularity in the research sector, stable labeled isotopes play a vital role in managing several diseases such as cancer and diabetes. Pharmaceutical research, biomedical research, environmental & ecological research, industrial and agricultural research are among the other most promising sectors for stable isotope-labeled compound application.

Market Dynamics

The global stable isotope-labeled compound is driven by increasing research activities in biotechnology, pharmaceutical, agricultural, biomedical sectors, coupled with rising proteomics research. The rising prevalence of various types of cancer worldwide is one of the key factors accelerating the market of stable isotope-labeled compounds in recent times. Ongoing studies on various drug toxicity to develop the most effective therapeutic and diagnostic techniques have raised the stable isotope-labeled compound's demand volume.

Increasing research activities in biotechnology, pharmaceutical, agricultural, biomedical sectors, coupled with rising proteomics research

The stable isotope-labeled compound has gained tremendous market in the field of biomedical research. Combining stable isotope-labeled techniques with mass spectroscopy allows rapid acquisition and interpretation of data, promoting stable isotope-labeled compounds in various fields such as absorption and distribution and metabolism excretion studies. Apart from this, the use of stable isotope-labeled compounds in various aspects of metabolism and pharmacokinetics of drugs and other foreign compounds in humans and animals is expected to boost the stable isotope-labeled compound during the forecast period.

Compound labeled with carbon-13 and deuterium has been useful in the past by the drug metabolism scientists and toxicologist to understand different drug disposition and their potential role in target organ toxicities. For instance, in 2014, PerkinElmer came up with a Syngistix and NexION atomic spectroscopy software platform solution. The product is designed to target trace metal or elements in drinking water, impurities in pharmaceuticals, and adulterants in food.

Rising prevalence of various types of cancer across the world

As per WHO 2018, cancer is the second leading cause of death worldwide, and till 2018 it is responsible for taking 9.6 million lives. Nearly 70% of deaths due to cancer occurs in low and middle-income countries. Currently, the most common types of cancers are- lung cancer (2.09 million), breast cancer (2.09 million), colorectal cancer (1.80 million), prostate (1.28 million), skin cancer (non-melanoma) (1.04 million), and stomach cancer (1.03 million). Stable isotope-labeled compounds are an essential technology used to study the molecular mechanisms by which nutraceuticals modulate and target cancer metabolism.

The compounds are used as exogenous nutrients and monitor their downstream metabolites labeling patterns, thus enabling the analysis of specific metabolic pathway activity via the relative production and consumption of the labeled metabolites. A growing number of cancer patients and rising cancer investigations are expected to build a massive market of stable isotope-labeled compounds in the forecast period. However, various studies are going on bioactive compounds' molecular activity and designing synergistic nutraceutical combinations that are still underutilized.

The growing use of stable isotopes in clinical diagnosis and research in the pediatric population creates a broad spectrum of opportunities for the market to grow in coming tenures

The stable isotope-labeled compounds are nonreactive, and nearly 6000 stable isotope-labeled compounds are commercially available for metabolic studies. As per various studies, it is currently accepted that these compounds show negligible biological side effects, which allows them to be used for pediatric treatment ethically. As compared to radioactive isotopes, stable isotopes labeled compounds show various advantages and can be safely administrated simultaneously to the same subject without compromising future studies.

The plasma volume from one sample required to analyze the isotope enrichment is small, allowing even preterm infants to be studied. These tracers are safe and may be particularly important for validating new treatment modalities such as gene therapy or novel drug treatments; thus, the growing demand for diagnostics and treatment from stable isotope-labeled compounds in the pediatric population is creating tremendous opportunities for the market to proliferate in the coming years.

COVID-19 Impact Analysis

The global outbreak of coronavirus has disrupted the entire lifestyle of the human system. Apart from losing lives daily due to COVID-19, many companies lost their business during the lockdown period. Due to COVID-19, a significant drop is seen in inpatient visits to the hospitals due to temporary lockdown and constraints implemented to prevent the disease from spreading in not-affected zones.

Apart from this, various research institutes have put their regular studies targeting stable isotope-labeled compounds due to ongoing research on COVID-19 treatment and diagnosis. Thus this sudden research shit and drop in cancer-positive patients in the hospital have hampered a massive market of stable isotope labeled compounds in recent times. The momentum is expected to maintain until the pandemic gets over.

Segment Analysis

The global stable isotope-labeled compounds market is segmented based on types, application end-user and region.

Growing pharmaceutical research using deuterium and improving nuclear study at an affordable cost

The stable isotope-labeled compounds market can be bifurcated into carbon 12 and cabon 13 , deuterium, oxygen 16 and oxygen 18, nitrogen-15, lithium 6 and lithium 7, chlorine 35 and chlorine 37, sulphur 34 and others in terms of type. Deuterium dominated the 2019 market of stable isotope-labeled compounds and is expected to maintain the conjecture period's market momentum. This segment's significant growth is due to growing pharmaceutical research using deuterium and improving the nuclear study.

Deuterium is mostly used by the toxicologist and metabolism scientists to identify the significant role in targeting organ toxicities and drug disposition. The deuterium isotope is the cheapest among all the pre-existing isotopes and is easiest to introduce into any molecule. Therefore, the growing application of deuterium in different healthcare sectors at an affordable cost is triggering its market in recent times.

Geographical Analysis

Growing pharmaceutical and biopharmaceutical industries in the region and increasing prevalence of cancer patients in North America

North America is expected to dominate the stable isotope-labeled compound market in the forecast period owing to growing pharmaceutical and biopharmaceutical industries in the region. The growing Canadian pharmaceutical industry and rising investments by the government in the U.S.'s nuclear industry trigger the research demand.

Related projects on the stable isotope-labeled compound are adding values to the growing market. As per National Cancer Institute, in 2020, an estimated 1,806,590 new cases have been diagnosed for cancer in the U.S., and nearly 606,520 people are expected to lose their lives. The growing numbers of cancer patients in the region and established infrastructure in the region boost the stable isotope-labeled compound for the past few years.

Competitive Landscape

The stable isotope-labeled compound market is highly fragmented with the presence of limited global companies. Some of the key players contributing to the market's growth include Perkinelmer, Cambridge Isotope Laboratories, Inc, Merck KGaA, URENCO Limited, Trace Sciences International, IsoSciences LLC, Omicron Biochemicals, Inc, Huayi Isotopes Co, Alsachim, Taiyo Nippon Sanso Corporation, and among others.

The significant players adopt several growth strategies such as product launches, acquisitions, and collaborations, contributing to the globally stable isotope-labeled compound market. The key players favor acquisition and collaboration as the growth strategy for building revenue for the company.

  • For instance, in 2018, Taiyo Nippon Sanso Corporation announced its complete acquisition of SAIL technologies Inc, a Japan-based manufacturer and distributor of stable isotope-labeled amino acids. The acquisition will strengthen the products for Taiyo Nippon Sanso Corporation and helped in increasing market share since 2018

Merck KGaA

Overview: Merck KGaA is a research-driven industrial company established in 1827. Emanuel Merck, founder of Merck KGaA, isolated and characterized alkaloids for distribution to chemists. The company also came up with a biotechnology production process and entered the market; currently, it is a global pharmaceutical, chemical, and life-science global leader.

Product Portfolio: The company has a product portfolio of stable isotope-labeled compound includes:

  • ISOTEC: It is a stable isotope that produces stable isotope products ranging from gases to complex molecules. Products include under ISOTEC are amino acids, bioactive compounds, carbohydrates, and salts- all with isotopic labeling. These products are used for tracing studies in proteomics and metabolomics studies

Key Development:

  • In November 2015, Merck KGaA acquired Sigma-Aldrich Corporation, and the company secured the second position as the global stable isotope-labeled compound market after this acquisition. This acquisition considerably expanded Merck KGaA geographical footprint especially targeting North America

Why Purchase the Report?

  • Visualize the stable isotope-labeled compound market segmentation by types, application end-user and highlight key commercial assets and players.
  • Identify commercial opportunities in the stable isotope-labeled compound market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of stable isotope-labeled compound market-level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global stable isotope-labeled compound market report would provide access to an approx: 61 market data table, 59 figures, and 214 pages.

Target Audience 2022

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Table of Contents

1. Global Stable Isotope Labeled Compound Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Stable Isotope Labeled Compound Market - Market Definition and Overview

3. Global Stable Isotope Labeled Compound Market - Executive Summary

  • 3.1. Market Snippet by Type
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by End-User
  • 3.4. Market Snippet by Region

4. Global Stable Isotope Labeled Compound Market-Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. By increasing research activities in biotechnology, pharmaceutical, agricultural, biomedical sectors, coupled with rising proteomics research.
      • 4.1.1.2. Rising prevalence of various types of cancer across the world
    • 4.1.2. Restraints:
      • 4.1.2.1. XX
    • 4.1.3. Opportunity
      • 4.1.3.1. The growing use of stable isotopes in clinical diagnosis and research in the pediatric population is creating a wide spectrum of opportunities for the market to grow in coming tenures
      • 4.1.3.2. XX
    • 4.1.4. Impact Analysis

5. Global Stable Isotope Labeled Compound Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. Global Stable Isotope Labeled Compound Market - COVID-19 Analysis

  • 6.1. Analysis of COVID-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Stable Isotope Labeled Compound Market - By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Deuterium*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Carbon 12 and Cabon 13
  • 7.4. Oxygen 16 and Oxygen 18
  • 7.5. Nitrogen 15
  • 7.6. Lithium 6 and Lithium 7
  • 7.7. Chlorine 35 and Chlorine 37
  • 7.8. Sulphur 34
  • 7.9. Others

8. Global Stable Isotope Labeled Compound Market - By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Research*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
      • 8.2.2.1. Biomedical Research
      • 8.2.2.2. Pharmaceutical Research
      • 8.2.2.3. Environmental & Ecological Research
      • 8.2.2.4. Agricultural Research
  • 8.3. Industrial
  • 8.4. Clinical Diagnostics
  • 8.5. Others

9. Global Stable Isotope Labeled Compound Market - By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Pharmaceutical and Biotechnology Companies*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Hospitals and Diagnostic Centers
  • 9.4. Academic & Research Institutes
  • 9.5. Others

10. Global Stable Isotope Labeled Compound Market - By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application.
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Russia
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User.
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Global Stable Isotope Labeled Compound Market - Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Global Stable Isotope Labeled Compound Market- Company Profiles

  • 12.1. Perkinelmer*
    • 12.1.1. Company Overview
    • 12.1.2. Type Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Cambridge Isotope Laboratories, Inc
  • 12.3. Merck KGaA
  • 12.4. URENCO Limited
  • 12.5. Trace Sciences International
  • 12.6. IsoSciences LLC
  • 12.7. Omicron Biochemicals, Inc
  • 12.8. Huayi Isotopes Co
  • 12.9. Alsachim
  • 12.10. Taiyo Nippon Sanso Corporation

LIST NOT EXHAUSTIVE

13. Global Stable Isotope Labeled Compound - Premium Insights

14. Global Stable Isotope Labeled Compound - DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us